Moreover, high IRF8 mRNA levels were found only in those CML patients who were classified as “good” cytogenetic responders to interferon-α therapy and not in the poor responders (60). Here, IRF8 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.